JDD March 2021 Issue Highlights: From OTC Products for Acne to MMS for Genital Skin Cancer
JDD MARCH 2021 ISSUEThe March issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from OTC products for acne to Mohs Micrographic Surgery for genital skin cancer. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Advisors agreed that OTC products and skincare recommendations, in addition to the use of prescription medications, …
JDD MARCH 2021 ISSUE
Severe Oral Mucositis: A Rare Adverse Event of Pembrolizumab
Oral MucositisTreatment of malignancy with anti-programmed cell death 1 (PD-1) immune checkpoint inhibitors can cause mucocutaneous side effects resulting from T cell activation. Due to their recent development, the full side effect profile remains to be fully elucidated, however dermatologic adverse events are most common. The main oral toxicities of these immune checkpoint inhibitors include: xerostomia, dysg …
Oral Mucositis
Easing the Management of Atopic Dermatitis
Atopic DermatitisDr. Friedman, jack of many trades, Professor and Interim Chair of Dermatology at George Washington University provided an excellent overview of ways to achieve victory over atopic dermatitis (AD). This expert discussion took place during the ODAC Inflammatory Diseases Symposium on December 3, 2020. How could we possibly cover atopic dermatitis in 20 minutes? Well, Dr. Friedman skillfully led us …
Atopic Dermatitis
Patient Buzz: COVID-19 & Telogen Effluvium
Telogen EffluviumVeryWell Health recently posted an article about a study that showed stress from COVID-19 -- and perhaps the virus itself – may be leading to an increase in hair loss cases. For an expert opinion, I contacted Chesahna Kindred, MD, MBA, FAAD, a dermatologist in practice in Columbia, Md. Has the pandemic led to an increase in telogen effluvium?  Absolutely. I noticed an increase in te …
Telogen Effluvium
Rapidly Enlarging Malignant Proliferating Trichilemmal Tumor
Trichilemmal Tumor Malignant proliferating trichilemmal tumors are rare adnexal neoplasms that most commonly occur on the scalp in elderly women. These tumors are associated with recurrence and even nodal or distant metastatic spread. Here, JDD authors describe a 38-year-old patient who presented with a scalp nodule that was diagnosed as a high-grade malignant proliferating trichilemmal tumor. Introduction Th …
Trichilemmal Tumor
error

Enjoy this blog? Please spread the word :)